UNSPSC 51391602: Aminophylline

This classification denotes a phosphodiesterase inhibitor and bronchodilator with the molecular formula 2C7H8N4O2.C2H8N2.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y7E0LU9ZMS. European Medicines Agency schedules aminophylline hydrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00461MIG. Most nations schedule aminophylline under HS 29395900 and SITC 54145. As of Q4 2014, AMINOPHYLLINE remains the US FDA Preferred Term for this commodity.

Aminophylline bears US NLM identifiers UMLS ID C0002575 and NCI Concept Code C47393. SMILES: CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N.O.

UNSPSC 51391602 Aminophylline, a Commodity code, shows minimal recent state and local activity directly aligned with its pharmaceutical scope. The two most recent opportunities posted under this code involve naloxone/drug deactivation systems and a pharmacy benefit direct-contracting initiative, neither of which represents aminophylline procurement. The code appears to see limited or mislabeled state and local solicitation activity; buyers seeking aminophylline or other specific pharmaceuticals typically source through established group purchasing organizations, state formularies, or health system contracts rather than through discrete competitive bidding cycles visible in open UNSPSC-tagged procurement records.

Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, reflecting community health and opioid-response procurement priorities rather than aminophylline. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to explore direct-to-manufacturer pharmacy contracting models, a strategic sourcing inquiry rather than a commodity purchase. Geographic activity is confined to Florida and Texas in these records. The absence of representative aminophylline-specific solicitations suggests that state and local pharmacy procurement under this code either operates through standing contracts outside the discrete IFB/RFQ cycle, uses different UNSPSC designations, or occurs infrequently enough to leave no recent open-market posting record.